

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| Concentration | Treated Time | Description | References | |
| HPAC cells | 1.2 nM (EC50) | 48 hours | To assess the impact of RMC-6236 on RAS pathway signaling in HPAC cells. Results showed sustained inhibition of pERK and pS6 and induction of apoptosis. | Cancer Discov. 2024 Jun 3;14(6):994-1017. |
| Capan-2 cells | 1.4 nM (EC50) | 48 hours | To assess the impact of RMC-6236 on RAS pathway signaling in Capan-2 cells. Results showed sustained inhibition of pERK and pS6. | Cancer Discov. 2024 Jun 3;14(6):994-1017. |
| 6419c5 or 2838c3 tumor cells | 100 nM | 48 hours | To assess the effect of RMC-6236 on MHC-I expression in tumor cells. Results showed that MHC-I expression was upregulated in tumor cells treated with RMC-6236. | Cancer Discov. 2025 Mar 7. |
| Administration | Dosage | Frequency | Description | References | ||
| C57BL/6 mice | Subcutaneous and orthotopic PDAC models | Oral gavage | 25 mg/kg | Once daily for 7 days | To evaluate the anti-tumor activity of RMC-6236 in PDAC models. Results showed that RMC-6236 led to tumor regressions and increased T cell infiltration in the tumor microenvironment. | Cancer Discov. 2025 Mar 7. |
| BALB/c nude mice | Capan-2 xenograft model | Oral gavage | 3, 10, or 25 mg/kg | Single dose or daily for 28 days | To assess the pharmacokinetic, pharmacodynamic, and antitumor activity of RMC-6236 in Capan-2 xenograft models. Results showed dose-dependent tumor regression and sustained RAS pathway inhibition. | Cancer Discov. 2024 Jun 3;14(6):994-1017. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.23mL 0.25mL 0.12mL |
6.16mL 1.23mL 0.62mL |
12.33mL 2.47mL 1.23mL |
|
| CAS号 | 2765081-21-6 |
| 分子式 | C44H58N8O5S |
| 分子量 | 811.05 |
| SMILES Code | CC(COC([C@H]1NN(C([C@H](CC2=NC3=CS2)NC([C@H]4C[C@@H]4C)=O)=O)CCC1)=O)(C)CC5=[C@@](N(CC)C6=C5C=C3C=C6)[C@@]7=C([C@H](C)OC)N=CC(N8CCN(C)CC8)=C7 |
| MDL No. | N/A |
| 别名 | RMC-6236 |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 250 mg/mL(308.24 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
沪公网安备 31011702889066号
沪ICP备2024050318号-1